ECSP003435A - NEW COMPOUNDS - Google Patents
NEW COMPOUNDSInfo
- Publication number
- ECSP003435A ECSP003435A ECSP003435A ECSP003435A EC SP003435 A ECSP003435 A EC SP003435A EC SP003435 A ECSP003435 A EC SP003435A EC SP003435 A ECSP003435 A EC SP003435A
- Authority
- EC
- Ecuador
- Prior art keywords
- compound
- new compounds
- provides
- peaks
- xrpd
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000000034 method Methods 0.000 abstract 2
- MBTIMBGMQDTCIK-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione dihydrate hydrochloride Chemical compound O.O.Cl.S1C(NC(C1)=O)=O MBTIMBGMQDTCIK-UHFFFAOYSA-N 0.000 abstract 1
- 238000002441 X-ray diffraction Methods 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000002329 infrared spectrum Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Dihidrato de hidrocloruro de 5-[4-[2-(N-metil-N-(2-piridinil)amino)etoxi)bencil]tiazolidina-2,4-diona, caracterizado porque: (i) proporciona un espectro infrarrojo que contiene picos a 3.392, 2.739, 1.751, 1.325 y 713 cm-1; y/o (ii) proporciona un método de difracción de rayos X a través de polvo (XRPD) que contiene picos a 9,1 12,0, 15,7, 16,3 y 19,82O; un procedimiento para preparar dicho compuesto, una composición farmacéutica que contiene dicho compuesto y el uso de dicho compuesto en medicina.5- [4- [2- (N-Methyl-N- (2-pyridinyl) amino) ethoxy) benzyl] thiazolidine-2,4-dione hydrochloride dihydrate, characterized in that: (i) provides an infrared spectrum containing peaks at 3,392, 2,739, 1,751, 1,325, and 713 cm-1; and / or (ii) provides a powder containing X-ray Diffraction (XRPD) method containing peaks at 9.1, 12.0, 15.7, 16.3, and 19.82O; a procedure for preparing said compound, a pharmaceutical composition containing said compound and the use of said compound in medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003435 ECSP003435A (en) | 2000-04-27 | 2000-04-27 | NEW COMPOUNDS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003435 ECSP003435A (en) | 2000-04-27 | 2000-04-27 | NEW COMPOUNDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003435A true ECSP003435A (en) | 2000-06-19 |
Family
ID=42041063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003435 ECSP003435A (en) | 2000-04-27 | 2000-04-27 | NEW COMPOUNDS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003435A (en) |
-
2000
- 2000-04-27 EC ECSP003435 patent/ECSP003435A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26121A1 (en) | NEW PHARMACEUTICAL COMPOUND | |
| EA200101101A1 (en) | NEW PHARMACEUTICAL PREPARATION | |
| EA200101102A1 (en) | NEW PHARMACEUTICAL PREPARATION | |
| ECSP034505A (en) | THE CHLORHYDRATE SALT OF 5- [4- (2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] TIAZOLIDIN-2, 4-DIONA | |
| PT1349855E (en) | 5-`4-`2-(n-methyl-n- (2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione mesylate salt | |
| ECSP003435A (en) | NEW COMPOUNDS | |
| ECSP034469A (en) | NEW PHARMACEUTICAL COMPOUND | |
| GB0021784D0 (en) | Novel pharmaceutical | |
| ECSP003434A (en) | NEW COMPOUNDS | |
| EA200300005A1 (en) | SALT THIAZOLIDINDION FOR THE TREATMENT OF DIABETES MELLITUS | |
| CY1107767T1 (en) | THIAZOLIDINODIONI PRODUCER AND USE OF IT AS ANTIBIOTIC | |
| AP1785A (en) | Tartrate salt of thiazolidinedione derivative. | |
| AP2002002684A0 (en) | 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical | |
| AP1738A (en) | Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione. | |
| ECSP003438A (en) | NEW COMPOUNDS | |
| ECSP003436A (en) | NEW COMPOUNDS | |
| SI1448559T1 (en) | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient | |
| ECSP982779A (en) | A HYDRATE OF MALEIC ACID SALT, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE IN MEDICINE |